These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China. Song H; Zhou H; Yang M; Tan S; Wang J; Xu Q; Liu H; Wei S Br J Ophthalmol; 2019 Jun; 103(6):831-836. PubMed ID: 30049802 [TBL] [Abstract][Full Text] [Related]
5. Clinical profile, imaging features and short term visual outcomes of Indian optic neuritis patients with and without seromarkers for myelin oligodendrocyte glycoprotein and neuromyelitis optica. Ambika S; Durgapriyadarshini S; Padmalakshmi K; Noronha V; Arjundas D Indian J Ophthalmol; 2022 Jan; 70(1):194-200. PubMed ID: 34937238 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial. Chen JJ; Tobin WO; Majed M; Jitprapaikulsan J; Fryer JP; Leavitt JA; Flanagan EP; McKeon A; Pittock SJ JAMA Ophthalmol; 2018 Apr; 136(4):419-422. PubMed ID: 29470571 [TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-positive optic neuritis]. Song HL; Wei SH Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):174-179. PubMed ID: 30841683 [No Abstract] [Full Text] [Related]
8. Treatment outcomes of first-ever episode of severe optic neuritis. Galetta K; Ryan S; Manzano G; Chibnik LB; Balaban D; Prasad S; Chwalisz BK; Salazar-Camelo A; Conway S; Levy M; Matiello M Mult Scler Relat Disord; 2022 Oct; 66():104020. PubMed ID: 35839615 [TBL] [Abstract][Full Text] [Related]
9. Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients. Zhao Y; Tan S; Chan TCY; Xu Q; Zhao J; Teng D; Fu H; Wei S Br J Ophthalmol; 2018 Oct; 102(10):1372-1377. PubMed ID: 29363529 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China. Zhao G; Chen Q; Huang Y; Li Z; Sun X; Lu P; Yan S; Wang M; Tian G J Neurol; 2018 Jan; 265(1):33-40. PubMed ID: 29101456 [TBL] [Abstract][Full Text] [Related]
12. Isolated myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in adults: The importance of age of onset and prognosis-related radiological features. Zhao J; Chen X; Zhang J; Liu L; Wang J; Zhu L Mult Scler Relat Disord; 2024 May; 85():105518. PubMed ID: 38447395 [TBL] [Abstract][Full Text] [Related]
13. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis in Canada. Garg A; Margolin E; Micieli JA Can J Neurol Sci; 2021 May; 48(3):321-326. PubMed ID: 32921335 [TBL] [Abstract][Full Text] [Related]
14. Epidemiologic and Clinical Characteristics of Optic Neuritis in Japan. Ishikawa H; Kezuka T; Shikishima K; Yamagami A; Hiraoka M; Chuman H; Nakamura M; Hoshi K; Goseki T; Mashimo K; Mimura O; Yoshitomi T; Tanaka K; Ophthalmology; 2019 Oct; 126(10):1385-1398. PubMed ID: 31196727 [TBL] [Abstract][Full Text] [Related]
15. Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein. Ducloyer JB; Michel L; Wiertlewski S; Lebranchu P Eur J Ophthalmol; 2019 Mar; 29(2):257-261. PubMed ID: 29972029 [TBL] [Abstract][Full Text] [Related]
17. Plasma exchange response in 34 patients with severe optic neuritis. Deschamps R; Gueguen A; Parquet N; Saheb S; Driss F; Mesnil M; Vignal C; Aboab J; Depaz R; Gout O J Neurol; 2016 May; 263(5):883-887. PubMed ID: 26964539 [TBL] [Abstract][Full Text] [Related]
18. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B; J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206 [TBL] [Abstract][Full Text] [Related]
19. Myelin Oligodendrocyte Glycoprotein (MOG) Optic Neuritis: A Case Series. Nurul-Ain M; Khairul Kamal ZN; Wan Hitam WH; Abd Munaaim M; Mohd Zaki F Cureus; 2021 Apr; 13(4):e14452. PubMed ID: 33996312 [TBL] [Abstract][Full Text] [Related]
20. Resolution of myelin oligodendrocyte glycoprotein (MOG)-IgG optic neuritis without treatment. Vosoughi AR; Micieli JA Mult Scler Relat Disord; 2020 Nov; 46():102456. PubMed ID: 32853896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]